Clinical Trial Update: A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial of ONTAK with CHOP in newly diagnosed peripheral T-cell lymphoma completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
• ONTAK (denileukin diftitox)

Snippet

Sponsor: Eisai Inc. | Conditions: Lymphoma, T-Cell, Peripheral | Phase 2 | Status: COMPLETED | Results posted: 2020-03-18